IAM217 An investigational KIF18A inhibitor undergoing IND-enabling development for cancer.
Visit productCosigns Received
Be the first Cosign
Put your name behind IAM217.
Add it to your Products I use list and share why you use it.
IAM217 An investigational KIF18A inhibitor undergoing IND-enabling development for cancer.
Visit productBe the first Cosign
Add it to your Products I use list and share why you use it.